EDITORIAL
Published on 12 Jan 2023
Editorial: Combining chemo/radio therapy and immunotherapy for cancers—perfect mix of old and new
doi 10.3389/fimmu.2022.1129623
- 1,318 views
- 1 citation
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Combining Chemo/radio Therapy and Immunotherapy for Cancers—Perfect Mix of Old and New
Combining Chemo/radio Therapy and Immunotherapy for Cancers—Perfect Mix of Old and New
126k
Total downloads
317k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 13 Oct 2022
A novel inflammation-related lncRNAs prognostic signature identifies LINC00346 in promoting proliferation, migration, and immune infiltration of glioma
doi 10.3389/fimmu.2022.810572
- 1,581 views
- 7 citations
CLINICAL TRIAL
Published on 09 Sep 2022
Sintilimab maintenance therapy post first-line cytokine-induced killer cells plus chemotherapy for extensive-stage small cell lung cancer
doi 10.3389/fonc.2022.852885
- 1,445 views
- 5 citations
ORIGINAL RESEARCH
Published on 21 Jun 2022
Potential Determinants for Radiation-Induced Lymphopenia in Patients With Breast Cancer Using Interpretable Machine Learning Approach
doi 10.3389/fimmu.2022.768811
- 2,562 views
- 18 citations
CASE REPORT
Published on 20 Jun 2022
Complete Response to Immunotherapy Combined With Chemotherapy in a Patient With Gynecological Mixed Cancer Mainly Composed of Small Cell Neuroendocrine Carcinoma With High Tumor Mutational Burden: A Case Report
doi 10.3389/fonc.2022.750970
- 1,389 views
- 1 citation
CLINICAL TRIAL
Published on 02 Jun 2022
Tislelizumab Plus Chemotherapy Sequential Neoadjuvant Therapy for Non-cCR Patients After Neoadjuvant Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma (ETNT): An Exploratory Study
doi 10.3389/fimmu.2022.853922
- 2,051 views
- 10 citations
ORIGINAL RESEARCH
Published on 20 May 2022
PD-L1 Protein Expression Is Associated With Good Clinical Outcomes and Nomogram for Prediction of Disease Free Survival and Overall Survival in Breast Cancer Patients Received Neoadjuvant Chemotherapy
doi 10.3389/fimmu.2022.849468
- 3,029 views
- 7 citations
ORIGINAL RESEARCH
Published on 21 Apr 2022
Neoadjuvant Chemoradiotherapy Changes the Landscape of Soluble Immune Checkpoint Molecules in Patients With Locally Advanced Rectal Cancer
doi 10.3389/fonc.2022.756811
- 1,757 views
- 9 citations
ORIGINAL RESEARCH
Published on 17 Mar 2022
Efficacy and Safety of Low-Dose Nab-Paclitaxel Plus Tislelizumab in Elderly Patients With Previously Treated Metastatic Non-Small Cell Lung Cancer
doi 10.3389/fonc.2022.802467
- 2,754 views
- 8 citations
ORIGINAL RESEARCH
Published on 11 Mar 2022
Perioperative Outcomes of Minimally Invasive Esophagectomy After Neoadjuvant Immunotherapy for Patients With Locally Advanced Esophageal Squamous Cell Carcinoma
doi 10.3389/fimmu.2022.848881
- 2,623 views
- 22 citations
REVIEW
Published on 28 Feb 2022
Immunological Classification of Tumor Types and Advances in Precision Combination Immunotherapy
doi 10.3389/fimmu.2022.790113
- 9,950 views
- 37 citations
ORIGINAL RESEARCH
Published on 23 Feb 2022
Associations of HER2 Mutation With Immune-Related Features and Immunotherapy Outcomes in Solid Tumors
doi 10.3389/fimmu.2022.799988
- 3,810 views
- 12 citations
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore